Cargando…
Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment
BACKGROUND: Photothermal therapy (PTT) has received extensive attention owing to its non-invasive nature and highly therapeutic outcomes. PTT agents and near-infrared (NIR) laser are essential elements in PTT. However, most PTT agents are composed of heavy metals, characterized by serious cytotoxici...
Autores principales: | Li, Bin, Jiang, Zhongyin, Xie, Diya, Wang, Yiqing, Lao, Xingzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231502/ https://www.ncbi.nlm.nih.gov/pubmed/30510418 http://dx.doi.org/10.2147/IJN.S175334 |
Ejemplares similares
-
Nitroxide radical-modified CuS nanoparticles for CT/MRI imaging-guided NIR-II laser responsive photothermal cancer therapy
por: Xia, Chengwan, et al.
Publicado: (2018) -
The Ultrasmall Biocompatible CuS@BSA Nanoparticle and Its Photothermal Effects
por: Wan, Xiaofang, et al.
Publicado: (2019) -
Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer
por: Jang, Bian, et al.
Publicado: (2018) -
Biomimetic CuS nanoparticles for radiosensitization with mild photothermal therapy and GSH-depletion
por: Zhou, Xiaoxiang, et al.
Publicado: (2022) -
CuS@BSA-NB2 Nanoparticles for HER2-Targeted Photothermal Therapy
por: Ying, Ming, et al.
Publicado: (2022)